Induction of antigen-specific immune responses in melanoma patients after vaccination with peptide-pulsed dendritic cells.

Induction of antigen-specific immune responses in melanoma patients after vaccination with peptide-pulsed dendritic cells.

Détails bibliographiques
Auteurs principaux:	Mackensen, A, Herbst, B, Chen, J, Kohler, G, Herr, W, Cerundolo, V, Lindemann, A
Format:	Journal article
Publié:	1999

Documents similaires

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.
par: Mackensen, A, et autres
Publié: (2000)

Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology.
par: Oelke, M, et autres
Publié: (2000)

Dendritic cells and melanoma therapy.
par: Goding, C
Publié: (2009)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
par: Kloverpris, H, et autres
Publié: (2012)

The immune response to melanoma is limited by thymic selection of self-antigens.
par: Trager, U, et autres
Publié: (2012)

Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
par: Salio, M, et autres
Publié: (2003)

Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
par: Oelke, M, et autres
Publié: (2000)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
par: Chan, S
Publié: (2022)

Antigen presentation. Naturally processed peptides.
par: Elliott, T, et autres
Publié: (1990)

Harnessing invariant NKT-cells to enhance antigen specific immune responses
par: Cerundolo, V
Publié: (2014)

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
par: Buschow, S, et autres
Publié: (2017)

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.
par: Oxenius, A, et autres
Publié: (1999)

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines
par: Stephens, AJ, et autres
Publié: (2021)

Dynamic aspects of antigen binding to B cells in immune induction.
par: Wilson, J, et autres
Publié: (1972)

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
par: Anichini, A, et autres
Publié: (1999)

Immunotherapy of melanoma.
par: Smith, C, et autres
Publié: (2001)

MVA85A: characterising the innate immune responses after vaccination and the effect of TLR1 levels on the acquired antigen-specific immune response
par: Kostov, M, et autres
Publié: (2011)

A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
par: Galea-Lauri, J, et autres
Publié: (2001)

Stimulation of dendritic cells enhances immune response after photodynamic therapy
par: Mroz, Pawel, et autres
Publié: (2010)

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
par: Dhodapkar, M, et autres
Publié: (1999)

Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.
par: Salio, M, et autres
Publié: (2003)

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells.
par: Schuler-Thurner, B, et autres
Publié: (2000)

Harnessing Invariant Natural Killer T Cells to Abolish the Suppressive Activity of Myeloid-derived Suppressor Cells and Restore Melanoma-specific Immune Response
par: Cerundolo, V
Publié: (2009)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
par: Chen, T, et autres
Publié: (2004)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
par: Chen, T, et autres
Publié: (2004)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
par: Galea-Lauri, J, et autres
Publié: (2001)

Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.
par: Markey, K, et autres
Publié: (2012)

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.
par: Mcshane, H, et autres
Publié: (2002)

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
par: Galea-Lauri, J, et autres
Publié: (2004)

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
par: Palmowski, M, et autres
Publié: (2002)

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients.
par: Speiser, D, et autres
Publié: (2010)

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.
par: Lopes, L, et autres
Publié: (2008)

Shaping humoral immunity to vaccines through antigen-displaying nanoparticles
par: Irvine, Darrell J, et autres
Publié: (2020)

Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig
par: Tungatt, K, et autres
Publié: (2018)

Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
par: Oelke, M, et autres
Publié: (2000)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
par: Horowitz, A, et autres
Publié: (2012)

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.
par: Jones, E, et autres
Publié: (2002)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
par: Galea-Lauri, J, et autres
Publié: (2002)

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
par: Smith, C, et autres
Publié: (2005)

Harnessing dendritic cells for the induction of transplantation tolerance.
par: Silk, K, et autres
Publié: (2009)